Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Zipdrug

Explore full profile

Zipdrug helps health plans manage medication adherence and cost

New York City, United StatesFounded 2015Health Tech & Medtech
Valuation $50–100M Last recorded · 2019
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Zipdrug and the history behind them.

About Zipdrug

ZipDrug, now part of IngenioRx, is a healthcare service that simplifies the pharmacy experience by connecting patients to top-quality pharmacies and delivering lower-cost prescriptions directly to their homes. The company primarily serves Medicare Advantage patients, who often require recurring chronic medications. Operating in the healthcare market, ZipDrug dynamically allocates patients to pharmacies that ensure the best adherence at the lowest cost. The business model revolves around partnering with health plans and pharmacies to boost medication adherence, lower costs, and enhance the member experience. ZipDrug generates revenue through its partnerships with health plans and pharmacies, which are rewarded for ensuring patients continue to take their medications. Currently, ZipDrug's Pharmacy Network is available in 24 states, providing a significant reach across the United States.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2015
Headquarters
New York City, United States
Employees
7
Open positions
None listed
Dealroom signal
63.9/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Medication Adherence, Pharmacy, Hard Tech
Client focus
b2b

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Jul 2020 $0 — IngenioRx —
EARLY VCOther financing Feb 2019 $11M $43M Runa Capital · Nat Turner · Compound · Lux Capital —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Zipdrug website traffic

Latest recorded traffic for Zipdrug is 1.2K monthly website visits, down 42.9% over the last three months. Zipdrug's team declined 77.4% over the past year.

Latest monthly visits1.2K 3-month web change-42.9% 1-year team growth-77.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

20 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed12 investors entered at this stage

Series A3 investors entered at this stage

Other known investors5 additional known investors

  • IngenioRx
  • BAM Ventures
  • Romain Afflelou
  • Runway Venture Partners
  • Todd Kimmel
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Zipdrug on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Zipdrug’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.